We’re all anxiously awaiting news in 2020 about a successful vaccine for COVID19, with the Australian Government securing a ‘letter of intent’ with Oxford University and pharmaceutical giant AstraZeneca.

But, as we do at Think: Business Futures, it is important to take a closer look at the petri dish, and find out whether the vaccine could bust the virus, or break the bank?

Joining us is Dr. Richard De Abreu Lourenco, Associate Professor at the Centre for Health Economics Research and Evaluation at the University of Technology Sydney.

And Jennifer Herz, managing director of Biointellect, an Australian strategic planning and market research firm for the biopharmaceutical and medical device sector.